BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28255276)

  • 1. Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis.
    Zheng X; Pang B; Gu G; Gao T; Zhang R; Pang Q; Liu Q
    Int J Biol Sci; 2017; 13(2):245-253. PubMed ID: 28255276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
    Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
    J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
    Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
    Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
    Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2 expands breast stem cells through activation of NOTCH1 signaling.
    Gonzalez ME; Moore HM; Li X; Toy KA; Huang W; Sabel MS; Kidwell KM; Kleer CG
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3098-103. PubMed ID: 24516139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
    Chen M; Xia Z; Chen C; Hu W; Yuan Y
    Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Notch signaling in glioblastoma stem cells contributes to tumor recurrence and invasion.
    Yu JB; Jiang H; Zhan RY
    Mol Med Rep; 2016 Aug; 14(2):1263-8. PubMed ID: 27315154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.
    Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y
    Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
    Cheng T; Xu Y
    Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer.
    Shen Y; Cao J; Liang Z; Lin Q; Wang J; Yang X; Zhang R; Zong J; Du X; Peng Y; Zhang J; Shi J
    Cell Commun Signal; 2019 May; 17(1):50. PubMed ID: 31122254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
    Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
    Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
    Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
    J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.
    Yu T; Zhou F; Tian W; Xu R; Wang B; Zeng A; Zhou Z; Li M; Wang Y; Zhang J
    Oncogene; 2023 Feb; 42(6):461-470. PubMed ID: 36517590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1.
    Li Y; He ZC; Zhang XN; Liu Q; Chen C; Zhu Z; Chen Q; Shi Y; Yao XH; Cui YH; Zhang X; Wang Y; Kung HF; Ping YF; Bian XW
    Cancer Lett; 2018 Mar; 416():66-74. PubMed ID: 29196129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the expression of Notch1 and EZH2 and the prognosis of breast invasive ductal carcinoma.
    Zhao L; Zhang QY; Luan X; Huang X; Zhao S; Zhao H
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross Interaction between M2 Muscarinic Receptor and Notch1/EGFR Pathway in Human Glioblastoma Cancer Stem Cells: Effects on Cell Cycle Progression and Survival.
    Cristofaro I; Alessandrini F; Spinello Z; Guerriero C; Fiore M; Caffarelli E; Laneve P; Dini L; Conti L; Tata AM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32182759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM17 regulates self-renewal and differentiation of U87 glioblastoma stem cells.
    Chen X; Chen L; Zhang R; Yi Y; Ma Y; Yan K; Jiang X; Wang X
    Neurosci Lett; 2013 Mar; 537():44-9. PubMed ID: 23356982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.
    Zhu J; Yang DR; Sun Y; Qiu X; Chang HC; Li G; Shan Y; Chang C
    Mol Cancer Ther; 2015 Jun; 14(6):1445-53. PubMed ID: 25833838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells.
    Guichet PO; Guelfi S; Teigell M; Hoppe L; Bakalara N; Bauchet L; Duffau H; Lamszus K; Rothhut B; Hugnot JP
    Stem Cells; 2015 Jan; 33(1):21-34. PubMed ID: 24898819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.